These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 12640679

  • 1. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
    Kuniyasu H, Chihara Y, Kondo H.
    Int J Cancer; 2003 May 10; 104(6):722-7. PubMed ID: 12640679
    [Abstract] [Full Text] [Related]

  • 2. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages.
    Kuniyasu H, Yano S, Sasaki T, Sasahira T, Sone S, Ohmori H.
    Am J Pathol; 2005 Mar 10; 166(3):751-60. PubMed ID: 15743787
    [Abstract] [Full Text] [Related]

  • 3. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.
    Kuniyasu H, Chihara Y, Takahashi T.
    Oncol Rep; 2003 Mar 10; 10(2):445-8. PubMed ID: 12579287
    [Abstract] [Full Text] [Related]

  • 4. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
    Ishiguro H, Nakaigawa N, Miyoshi Y, Fujinami K, Kubota Y, Uemura H.
    Prostate; 2005 Jun 15; 64(1):92-100. PubMed ID: 15666359
    [Abstract] [Full Text] [Related]

  • 5. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI, Stanca L, Geicu OI, Munteanu MC, Costache M, Dinischiotu A.
    J Diabetes; 2015 Jan 15; 7(1):114-24. PubMed ID: 24666836
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.
    Tafani M, Schito L, Pellegrini L, Villanova L, Marfe G, Anwar T, Rosa R, Indelicato M, Fini M, Pucci B, Russo MA.
    Carcinogenesis; 2011 Aug 15; 32(8):1167-75. PubMed ID: 21642357
    [Abstract] [Full Text] [Related]

  • 7. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
    Zhu P, Ren M, Yang C, Hu YX, Ran JM, Yan L.
    Exp Dermatol; 2012 Feb 15; 21(2):123-9. PubMed ID: 22229442
    [Abstract] [Full Text] [Related]

  • 8. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.
    Kuniyasu H, Oue N, Wakikawa A, Shigeishi H, Matsutani N, Kuraoka K, Ito R, Yokozaki H, Yasui W.
    J Pathol; 2002 Feb 15; 196(2):163-70. PubMed ID: 11793367
    [Abstract] [Full Text] [Related]

  • 9. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    Riuzzi F, Sorci G, Donato R.
    J Biol Chem; 2006 Mar 24; 281(12):8242-53. PubMed ID: 16407300
    [Abstract] [Full Text] [Related]

  • 10. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
    Sharaf H, Matou-Nasri S, Wang Q, Rabhan Z, Al-Eidi H, Al Abdulrahman A, Ahmed N.
    Biochim Biophys Acta; 2015 Mar 24; 1852(3):429-41. PubMed ID: 25514746
    [Abstract] [Full Text] [Related]

  • 11. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.
    Bhawal UK, Ozaki Y, Nishimura M, Sugiyama M, Sasahira T, Nomura Y, Sato F, Fujimoto K, Sasaki N, Ikeda MA, Tsuji K, Kuniyasu H, Kato Y.
    Oncology; 2005 Mar 24; 69(3):246-55. PubMed ID: 16127291
    [Abstract] [Full Text] [Related]

  • 12. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
    Hirasawa Y, Sakai T, Ito M, Yoshimura H, Feng Y, Nagamatsu T.
    Eur J Pharmacol; 2011 Dec 15; 672(1-3):159-68. PubMed ID: 21989075
    [Abstract] [Full Text] [Related]

  • 13. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration.
    Chou DK, Zhang J, Smith FI, McCaffery P, Jungalwala FB.
    J Neurochem; 2004 Sep 15; 90(6):1389-401. PubMed ID: 15341523
    [Abstract] [Full Text] [Related]

  • 14. Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas.
    Sasahira T, Akama Y, Fujii K, Kuniyasu H.
    Virchows Arch; 2005 Apr 15; 446(4):411-5. PubMed ID: 15789216
    [Abstract] [Full Text] [Related]

  • 15. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer.
    Kuniyasu H, Chihara Y, Kondo H, Ohmori H, Ukai R.
    Oncol Rep; 2003 Apr 15; 10(6):1863-8. PubMed ID: 14534709
    [Abstract] [Full Text] [Related]

  • 16. N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth.
    Srikrishna G, Huttunen HJ, Johansson L, Weigle B, Yamaguchi Y, Rauvala H, Freeze HH.
    J Neurochem; 2002 Mar 15; 80(6):998-1008. PubMed ID: 11953450
    [Abstract] [Full Text] [Related]

  • 17. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.
    Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, Rauvala H.
    Cancer Res; 2002 Aug 15; 62(16):4805-11. PubMed ID: 12183440
    [Abstract] [Full Text] [Related]

  • 18. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site.
    Ishihara K, Tsutsumi K, Kawane S, Nakajima M, Kasaoka T.
    FEBS Lett; 2003 Aug 28; 550(1-3):107-13. PubMed ID: 12935895
    [Abstract] [Full Text] [Related]

  • 19. High-Mobility Group Box 1 Mediates Fibroblast Activity via RAGE-MAPK and NF-κB Signaling in Keloid Scar Formation.
    Kim J, Park JC, Lee MH, Yang CE, Lee JH, Lee WJ.
    Int J Mol Sci; 2017 Dec 28; 19(1):. PubMed ID: 29283384
    [Abstract] [Full Text] [Related]

  • 20. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation.
    Huttunen HJ, Kuja-Panula J, Rauvala H.
    J Biol Chem; 2002 Oct 11; 277(41):38635-46. PubMed ID: 12167613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.